MicroRNA-327 regulates cardiac hypertrophy and fibrosis induced by pressure overload
MicroRNA (miRNA/miR) dysregulation has been reported to be fundamental in the development and progression of cardiac hypertrophy and fibrosis. In the present study, miR-327 levels in fibroblasts were increased in response to cardiac hypertrophy induced by transverse aortic constriction with prominen...
Saved in:
Published in | International journal of molecular medicine Vol. 41; no. 4; pp. 1909 - 1916 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Greece
Spandidos Publications
01.04.2018
Spandidos Publications UK Ltd D.A. Spandidos |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | MicroRNA (miRNA/miR) dysregulation has been reported to be fundamental in the development and progression of cardiac hypertrophy and fibrosis. In the present study, miR-327 levels in fibroblasts were increased in response to cardiac hypertrophy induced by transverse aortic constriction with prominent cardiac fibrosis, particularly when compared with the levels in unstressed cardiomyocytes. In neonatal rat cardiac fibroblasts, induced expression of miR-327 upregulated fibrosis-associated gene expression and activated angiotensin II-induced differentiation into myofibroblasts, as assessed via α-smooth muscle actin staining. By contrast, miR-327 knockdown mitigated angiotensin II-induced differentiation. Cardiac fibroblast proliferation was not affected under either condition. In a mouse model subjected to transverse aortic constriction, miR-327 knockdown through tail-vein injection reduced the development of cardiac fibrosis and ventricular dysfunction. miR-327 was demonstrated to target integrin β3 and diminish the activation of cardiac fibroblasts. Thus, the present study supports the use of miR-327 as a therapeutic target in the reduction of cardiac fibrosis. |
---|---|
AbstractList | MicroRNA (miRNA/miR) dysregulation has been reported to be fundamental in the development and progression of cardiac hypertrophy and fibrosis. In the present study, miR-327 levels in fibroblasts were increased in response to cardiac hypertrophy induced by transverse aortic constriction with prominent cardiac fibrosis, particularly when compared with the levels in unstressed cardiomyocytes. In neonatal rat cardiac fibroblasts, induced expression of miR-327 upregulated fibrosis-associated gene expression and activated angiotensin II-induced differentiation into myofibroblasts, as assessed via α-smooth muscle actin staining. By contrast, miR-327 knockdown mitigated angiotensin II-induced differentiation. Cardiac fibroblast proliferation was not affected under either condition. In a mouse model subjected to transverse aortic constriction, miR-327 knockdown through tail-vein injection reduced the development of cardiac fibrosis and ventricular dysfunction. miR-327 was demonstrated to target integrin β3 and diminish the activation of cardiac fibroblasts. Thus, the present study supports the use of miR-327 as a therapeutic target in the reduction of cardiac fibrosis. MicroRNA (miRNA/miR) dysregulation has been reported to be fundamental in the development and progression of cardiac hypertrophy and fibrosis. In the present study, miR-327 levels in fibroblasts were increased in response to cardiac hypertrophy induced by transverse aortic constriction with prominent cardiac fibrosis, particularly when compared with the levels in unstressed cardiomyocytes. In neonatal rat cardiac fibroblasts, induced expression of miR-327 upregulated fibrosis-associated gene expression and activated angiotensin II-induced differentiation into myofibroblasts, as assessed via α-smooth muscle actin staining. By contrast, miR-327 knockdown mitigated angiotensin II-induced differentiation. Cardiac fibroblast proliferation was not affected under either condition. In a mouse model subjected to transverse aortic constriction, miR-327 knockdown through tail-vein injection reduced the development of cardiac fibrosis and ventricular dysfunction. miR-327 was demonstrated to target integrin β3 and diminish the activation of cardiac fibroblasts. Thus, the present study supports the use of miR-327 as a therapeutic target in the reduction of cardiac fibrosis. MicroRNA (miRNA/miR) dysregulation has been reported to be fundamental in the development and progression of cardiac hypertrophy and fibrosis. In the present study, miR-327 levels in fibroblasts were increased in response to cardiac hypertrophy induced by transverse aortic constriction with prominent cardiac fibrosis, particularly when compared with the levels in unstressed cardiomyocytes. In neonatal rat cardiac fibroblasts, induced expression of miR-327 upregulated fibrosis-associated gene expression and activated angiotensin Il-induced differentiation into myofibroblasts, as assessed via [alpha]-smooth muscle actin staining. By contrast, miR-327 knockdown mitigated angiotensin Il-induced differentiation. Cardiac fibroblast proliferation was not affected under either condition. In a mouse model subjected to transverse aortic constriction, miR-327 knockdown through tail-vein injection reduced the development of cardiac fibrosis and ventricular dysfunction. miR-327 was demonstrated to target integrin [beta]3 and diminish the activation of cardiac fibroblasts. Thus, the present study supports the use of miR-327 as a therapeutic target in the reduction of cardiac fibrosis. MicroRNA (miRNA/miR) dysregulation has been reported to be fundamental in the development and progression of cardiac hypertrophy and fibrosis. In the present study, miR-327 levels in fibroblasts were increased in response to cardiac hypertrophy induced by transverse aortic constriction with prominent cardiac fibrosis, particularly when compared with the levels in unstressed cardiomyocytes. In neonatal rat cardiac fibroblasts, induced expression of miR-327 upregulated fibrosis-associated gene expression and activated angiotensin Il-induced differentiation into myofibroblasts, as assessed via [alpha]-smooth muscle actin staining. By contrast, miR-327 knockdown mitigated angiotensin Il-induced differentiation. Cardiac fibroblast proliferation was not affected under either condition. In a mouse model subjected to transverse aortic constriction, miR-327 knockdown through tail-vein injection reduced the development of cardiac fibrosis and ventricular dysfunction. miR-327 was demonstrated to target integrin [beta]3 and diminish the activation of cardiac fibroblasts. Thus, the present study supports the use of miR-327 as a therapeutic target in the reduction of cardiac fibrosis. Abbreviations: BW, body weight; EF, ejection fraction; FBS, fetal bovine serum; FGF, fibroblast growth factor; HW, heart weight; LV, left ventricle; LVPW, left ventricular posterior wall; MAPK, mitogen-activated protein kinase; NRCF, neonatal rat cardiac fibroblasts; TAC, transverse aortic constriction; TL, tibia length Key words: microRNA-327, cardiac hypertrophy, fibrosis, integrin [beta]3 |
Audience | Academic |
Author | Sun, Wei Kong, Xiangqing Ji, Yue Wang, Yaqing Shen, Yejiao Lu, Yan Gao, Li Li, Xinli Qiu, Ming |
AuthorAffiliation | 1 Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University 2 Department of Cardiology, Graduate Institution of Integrated Medicine, Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China |
AuthorAffiliation_xml | – name: 1 Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University – name: 2 Department of Cardiology, Graduate Institution of Integrated Medicine, Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China |
Author_xml | – sequence: 1 givenname: Yue surname: Ji fullname: Ji, Yue organization: Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China – sequence: 2 givenname: Ming surname: Qiu fullname: Qiu, Ming organization: Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China – sequence: 3 givenname: Yejiao surname: Shen fullname: Shen, Yejiao organization: Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China – sequence: 4 givenname: Li surname: Gao fullname: Gao, Li organization: Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China – sequence: 5 givenname: Yaqing surname: Wang fullname: Wang, Yaqing organization: Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China – sequence: 6 givenname: Wei surname: Sun fullname: Sun, Wei organization: Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China – sequence: 7 givenname: Xinli surname: Li fullname: Li, Xinli organization: Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China – sequence: 8 givenname: Yan surname: Lu fullname: Lu, Yan organization: Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China – sequence: 9 givenname: Xiangqing surname: Kong fullname: Kong, Xiangqing organization: Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29393356$$D View this record in MEDLINE/PubMed |
BookMark | eNptkUtr3DAUhUVJaB7tNssiyNpTPSxL2hSG0EcgDwgJdCdkPWY02JYj2YH595VpmqQQ7kKXq3MPR_pOwMEQBwfAGUYrKiT5GnZ9vyIIixWtifgAjjGXuCJ1_fug9BjxinLWHIGTnHcIEVZL8REcEUklpaw5BvfXwaR4d7OuKOEwuc3c6cllaHSyQRu43Y8uTSmO2z3Ug4U-tCnmkGEY7Gyche0ejsnlPCcH45NLXdT2Ezj0usvu8_N5Ch5-fL-_-FVd3f68vFhfVaYWbKpoI7RBrcHSCtpKjxsupCsDwZm3tcWtYYZbaRqOjLZcYEE59cxT712DJD0F3_76jnPbO2vcMCXdqTGFXqe9ijqo_2-GsFWb-KSYwAjLxeD82SDFx9nlSe3inIaSWZU_JaImhNFX1UZ3ToXBx2Jm-pCNWjNKqGhqgYpq9Y6qlHV9MIWaD2X-3kIBkHNy_iU4RmqBqxa4SxChFrhl4cvb577I_9GkfwCAhaJx |
CitedBy_id | crossref_primary_10_1139_cjpp_2018_0430 crossref_primary_10_2147_DMSO_S248948 crossref_primary_10_3389_fphar_2021_669146 crossref_primary_10_3389_fphar_2023_1092148 crossref_primary_10_3390_genes13081390 |
Cites_doi | 10.1126/scitranslmed.3009008 10.1172/JCI74368 10.1038/nrm3495 10.1158/1078-0432.CCR-12-2736 10.1161/HYPERTENSIONAHA.109.135467 10.1038/nrm1983 10.1073/pnas.0502256102 10.1007/s00018-013-1349-6 10.1152/physrev.00054.2009 10.1093/jrr/rrw069 10.1152/physiolgenomics.00130.2010 10.7150/thno.15007 10.1038/ncb2866 10.1161/01.CIR.103.5.670 10.1038/nature09783 10.1016/S0735-1097(01)01790-9 10.1038/nature07511 10.3390/ijms17050749 10.1161/CIRCHEARTFAILURE.113.000266 10.3892/ijmm.2017.3152 10.3892/ijmm.2015.2105 10.1016/j.ccr.2013.05.004 10.1177/1087057110397359 10.1038/npp.2015.51 10.1002/ejhf.696 10.1038/nrcardio.2012.158 10.1074/mcp.M110.005397 10.1253/jcj.61.91 10.1161/CIRCRESAHA.113.300226 10.1038/nrcardio.2014.125 10.1186/1476-511X-11-55 10.1111/jcmm.12445 10.1016/j.jacc.2013.09.041 10.3892/ijmm.2017.3021 10.1074/jbc.M109.027896 10.1074/jbc.M801296200 10.1517/14728222.2014.1001740 10.1371/journal.pone.0123477 10.1006/meth.2001.1262 10.1038/nrd4140 10.1186/1479-5876-11-222 10.1111/j.1582-4934.2012.01523.x 10.1016/B978-0-12-387786-4.00009-9 10.1016/j.bcp.2016.11.008 10.5603/KP.a2015.0174 10.1161/CIRCULATIONAHA.112.125013 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2018 Spandidos Publications Copyright Spandidos Publications UK Ltd. 2018 Copyright: © Ji et al. 2018 |
Copyright_xml | – notice: COPYRIGHT 2018 Spandidos Publications – notice: Copyright Spandidos Publications UK Ltd. 2018 – notice: Copyright: © Ji et al. 2018 |
DBID | NPM AAYXX CITATION 3V. 7X7 7XB 88E 8AO 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH K9. M0S M1P PQEST PQQKQ PQUKI PRINS 5PM |
DOI | 10.3892/ijmm.2018.3428 |
DatabaseName | PubMed CrossRef ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) Medical Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China PubMed Central (Full Participant titles) |
DatabaseTitle | PubMed CrossRef ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Pharma Collection ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest One Academic ProQuest Medical Library (Alumni) ProQuest Central (Alumni) |
DatabaseTitleList | PubMed ProQuest One Academic Eastern Edition |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X7 name: Health & Medical Collection url: https://search.proquest.com/healthcomplete sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1791-244X |
EndPage | 1916 |
ExternalDocumentID | A532386480 10_3892_ijmm_2018_3428 29393356 |
Genre | Journal Article |
GeographicLocations | Beijing China United States--US China |
GeographicLocations_xml | – name: China – name: Beijing China – name: United States--US |
GroupedDBID | NPM --- 0R~ 2WC 3V. 53G 5GY 7X7 88E 8AO 8FI 8FJ AAYXX ABJNI ABUWG ACGFO ACGFS ADBBV AEGXH AENEX AFKRA AHMBA AIAGR ALIPV ALMA_UNASSIGNED_HOLDINGS BAWUL BENPR BPHCQ BVXVI C45 CCPQU CITATION CS3 DIK DU5 E3Z EBD EBS EJD EMOBN F5P FRP FYUFA H13 HMCUK HUR HZ~ IAO IHR INH INR IPNFZ ITC M1P O9- OK1 OVD P2P PQQKQ PROAC PSQYO RIG SV3 TEORI TR2 UKHRP 7XB 8FK K9. PQEST PQUKI PRINS 5PM |
ID | FETCH-LOGICAL-c485t-368ac0bc19d83b9f16789e0bc875fd4d1bc5c7d9c670cad7818373f5f3ffe6093 |
IEDL.DBID | BENPR |
ISSN | 1107-3756 |
IngestDate | Tue Sep 17 21:34:12 EDT 2024 Thu Oct 10 17:51:21 EDT 2024 Thu Feb 22 23:30:07 EST 2024 Wed Jan 10 03:57:39 EST 2024 Fri Aug 23 00:58:51 EDT 2024 Wed Oct 16 01:00:56 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | true |
Issue | 4 |
Language | English |
License | This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c485t-368ac0bc19d83b9f16789e0bc875fd4d1bc5c7d9c670cad7818373f5f3ffe6093 |
Notes | Contributed equally |
OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC5810199 |
PMID | 29393356 |
PQID | 2012842253 |
PQPubID | 2044958 |
PageCount | 8 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_5810199 proquest_journals_2012842253 gale_infotracmisc_A532386480 gale_infotracacademiconefile_A532386480 crossref_primary_10_3892_ijmm_2018_3428 pubmed_primary_29393356 |
PublicationCentury | 2000 |
PublicationDate | 2018-04-01 |
PublicationDateYYYYMMDD | 2018-04-01 |
PublicationDate_xml | – month: 04 year: 2018 text: 2018-04-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Greece |
PublicationPlace_xml | – name: Greece – name: Athens |
PublicationTitle | International journal of molecular medicine |
PublicationTitleAlternate | Int J Mol Med |
PublicationYear | 2018 |
Publisher | Spandidos Publications Spandidos Publications UK Ltd D.A. Spandidos |
Publisher_xml | – name: Spandidos Publications – name: Spandidos Publications UK Ltd – name: D.A. Spandidos |
References | 21622897 - Mol Cell Proteomics. 2011 Oct;10(10):M110.005397 25583328 - J Cell Mol Med. 2015 Mar;19(3):608-19 25652534 - Expert Opin Ther Targets. 2015 May;19(5):707-16 28157267 - Eur J Heart Fail. 2017 Feb;19(2):177-191 19901160 - Hypertension. 2010 Jan;55(1):137-43 11849867 - J Am Coll Cardiol. 2002 Feb 20;39(4):672-5 19706597 - J Biol Chem. 2009 Oct 23;284(43):29514-25 22811579 - Circulation. 2012 Aug 14;126(7):800-2 23258295 - Nat Rev Mol Cell Biol. 2013 Jan;14(1):38-48 23344261 - Clin Cancer Res. 2013 Feb 15;19(4):809-20 24898744 - Sci Transl Med. 2014 Jun 4;6(239):239ps3 26365938 - Kardiol Pol. 2016;74(3):280-8 11846609 - Methods. 2001 Dec;25(4):402-8 22260784 - J Cell Mol Med. 2012 Sep;16(9):2150-60 24161319 - J Am Coll Cardiol. 2014 Mar 11;63(9):920-7 27422938 - J Radiat Res. 2017 Jan;58(1):24-32 28977053 - Arq Bras Cardiol. 2017 Nov;109 (5):404-409 25938589 - PLoS One. 2015 May 04;10 (5):e0123477 9070966 - Jpn Circ J. 1997 Feb;61(2):91-118 28949388 - Int J Mol Med. 2017 Nov;40(5):1511-1519 27698941 - Theranostics. 2016 Sep 10;6(12 ):2068-2083 19043405 - Nature. 2008 Dec 18;456(7224):980-4 22449848 - Curr Top Dev Biol. 2012;100:279-317 20959496 - Physiol Genomics. 2011 May 1;43(10):534-42 25695617 - Int J Mol Med. 2015 Apr;35(4):893-900 24449811 - Circ Heart Fail. 2014 Jan;7(1):203-14 20959622 - Physiol Rev. 2010 Oct;90(4):1507-46 25684064 - Neuropsychopharmacology. 2015 Jul;40(8):2015-24 16936699 - Nat Rev Mol Cell Biol. 2006 Aug;7(8):589-600 25365073 - J Clin Invest. 2014 Nov;124(11):4673-7 23207731 - Nat Rev Cardiol. 2013 Jan;10(1):15-26 24161931 - Nat Cell Biol. 2013 Nov;15(11):1282-93 25200283 - Nat Rev Cardiol. 2014 Nov;11(11):655-63 23989712 - Circ Res. 2013 Aug 30;113(6):676-89 24053180 - J Transl Med. 2013 Sep 23;11:222 21248840 - Nature. 2011 Jan 20;469(7330):336-42 11156878 - Circulation. 2001 Feb 6;103(5):670-7 23770013 - Cancer Cell. 2013 Jul 8;24(1):45-58 15860581 - Proc Natl Acad Sci U S A. 2005 May 10;102(19):6936-41 27836671 - Biochem Pharmacol. 2017 Jan 1;123:40-51 28627582 - Int J Mol Med. 2017 Aug;40(2):523-530 27213331 - Int J Mol Sci. 2016 May 18;17 (5) 18477567 - J Biol Chem. 2008 Aug 8;283(32):22295-303 22587332 - Lipids Health Dis. 2012 May 15;11:55 24172333 - Nat Rev Drug Discov. 2013 Nov;12(11):847-65 21310850 - J Biomol Screen. 2011 Mar;16(3):313-22 23649149 - Cell Mol Life Sci. 2014 Feb;71(4):549-74 Espinoza-Lewis (key20200713174738_b12-ijmm-41-04-1909) 2012; 100 Huang (key20200713174738_b1-ijmm-41-04-1909) 2015; 19 Dong (key20200713174738_b37-ijmm-41-04-1909) 2009; 284 Gacoń (key20200713174738_b30-ijmm-41-04-1909) 2016; 74 Dirkx (key20200713174738_b24-ijmm-41-04-1909) 2013; 15 Haq (key20200713174738_b42-ijmm-41-04-1909) 2001; 103 Esposito (key20200713174738_b41-ijmm-41-04-1909) 2010; 55 Tao (key20200713174738_b3-ijmm-41-04-1909) 2016; 6 Irelan (key20200713174738_b19-ijmm-41-04-1909) 2011; 16 Kumarswamy (key20200713174738_b11-ijmm-41-04-1909) 2013; 113 Small (key20200713174738_b13-ijmm-41-04-1909) 2011; 469 Heineke (key20200713174738_b22-ijmm-41-04-1909) 2006; 7 Mazalouskas (key20200713174738_b47-ijmm-41-04-1909) 2015; 40 Gao (key20200713174738_b31-ijmm-41-04-1909) 2015; 10 Chien (key20200713174738_b2-ijmm-41-04-1909) 1997; 61 Xing (key20200713174738_b20-ijmm-41-04-1909) 2005; 102 Shi (key20200713174738_b14-ijmm-41-04-1909) 2017; 58 Roncarati (key20200713174738_b26-ijmm-41-04-1909) 2014; 63 Ling (key20200713174738_b29-ijmm-41-04-1909) 2013; 12 Miller (key20200713174738_b46-ijmm-41-04-1909) 2013; 24 Weber (key20200713174738_b40-ijmm-41-04-1909) 2013; 10 Wang (key20200713174738_b35-ijmm-41-04-1909) 2012; 16 Yang (key20200713174738_b7-ijmm-41-04-1909) 2017; 40 Thum (key20200713174738_b9-ijmm-41-04-1909) 2014; 11 Rose (key20200713174738_b44-ijmm-41-04-1909) 2010; 90 Melman (key20200713174738_b25-ijmm-41-04-1909) 2014; 7 Kong (key20200713174738_b38-ijmm-41-04-1909) 2014; 71 Thannickal (key20200713174738_b4-ijmm-41-04-1909) 2014; 124 Wang (key20200713174738_b33-ijmm-41-04-1909) 2013; 11 Tao (key20200713174738_b10-ijmm-41-04-1909) 2015; 19 Maillet (key20200713174738_b23-ijmm-41-04-1909) 2013; 14 Gyöngyösi (key20200713174738_b39-ijmm-41-04-1909) 2017; 19 Lei (key20200713174738_b45-ijmm-41-04-1909) 2011; 10 Lu (key20200713174738_b16-ijmm-41-04-1909) 2017; 123 Olson (key20200713174738_b6-ijmm-41-04-1909) 2014; 6 Livak (key20200713174738_b21-ijmm-41-04-1909) 2001; 25 Bourajjaj (key20200713174738_b15-ijmm-41-04-1909) 2008; 283 Cheng (key20200713174738_b18-ijmm-41-04-1909) 2017; 109 Gao (key20200713174738_b32-ijmm-41-04-1909) 2012; 11 Thum (key20200713174738_b5-ijmm-41-04-1909) 2012; 126 Wu (key20200713174738_b28-ijmm-41-04-1909) 2015; 35 Thum (key20200713174738_b34-ijmm-41-04-1909) 2008; 456 Wang (key20200713174738_b27-ijmm-41-04-1909) 2016; 17 Peterson (key20200713174738_b43-ijmm-41-04-1909) 2002; 39 Ye (key20200713174738_b36-ijmm-41-04-1909) 2011; 43 Zhou (key20200713174738_b8-ijmm-41-04-1909) 2017; 40 Zaid (key20200713174738_b17-ijmm-41-04-1909) 2013; 19 |
References_xml | – volume: 6 start-page: 239ps3 year: 2014 ident: key20200713174738_b6-ijmm-41-04-1909 article-title: Micrornas as therapeutic targets and biomarkers of cardiovascular disease publication-title: Sci Transl Med doi: 10.1126/scitranslmed.3009008 contributor: fullname: Olson – volume: 124 start-page: 4673 year: 2014 ident: key20200713174738_b4-ijmm-41-04-1909 article-title: Fibrosis: Ultimate and proximate causes publication-title: J Clin Invest doi: 10.1172/JCI74368 contributor: fullname: Thannickal – volume: 14 start-page: 38 year: 2013 ident: key20200713174738_b23-ijmm-41-04-1909 article-title: Molecular basis of physiological heart growth: Fundamental concepts and new players publication-title: Nat Rev Mol Cell Biol doi: 10.1038/nrm3495 contributor: fullname: Maillet – volume: 19 start-page: 809 year: 2013 ident: key20200713174738_b17-ijmm-41-04-1909 article-title: Identification of FGFR4 as a potential therapeutic target for advanced-stage, high-grade serous ovarian cancer publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-12-2736 contributor: fullname: Zaid – volume: 55 start-page: 137 year: 2010 ident: key20200713174738_b41-ijmm-41-04-1909 article-title: Induction of mitogen-activated protein kinases is proportional to the amount of pressure overload publication-title: Hypertension doi: 10.1161/HYPERTENSIONAHA.109.135467 contributor: fullname: Esposito – volume: 7 start-page: 589 year: 2006 ident: key20200713174738_b22-ijmm-41-04-1909 article-title: Regulation of cardiac hypertrophy by intracellular signalling pathways publication-title: Nat Rev Mol Cell Biol doi: 10.1038/nrm1983 contributor: fullname: Heineke – volume: 102 start-page: 6936 year: 2005 ident: key20200713174738_b20-ijmm-41-04-1909 article-title: A genetically defined mouse ovarian carcinoma model for the molecular characterization of pathway-targeted therapy and tumor resistance publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0502256102 contributor: fullname: Xing – volume: 71 start-page: 549 year: 2014 ident: key20200713174738_b38-ijmm-41-04-1909 article-title: The pathogenesis of cardiac fibrosis publication-title: Cell Mol Life Sci doi: 10.1007/s00018-013-1349-6 contributor: fullname: Kong – volume: 90 start-page: 1507 year: 2010 ident: key20200713174738_b44-ijmm-41-04-1909 article-title: Mitogen-activated protein kinase signaling in the heart: Angels versus demons in a heart-breaking tale publication-title: Physiol Rev doi: 10.1152/physrev.00054.2009 contributor: fullname: Rose – volume: 58 start-page: 24 year: 2017 ident: key20200713174738_b14-ijmm-41-04-1909 article-title: Protective effects of seabuckthorn pulp and seed oils against radiation-induced acute intestinal injury publication-title: J Radiat Res doi: 10.1093/jrr/rrw069 contributor: fullname: Shi – volume: 43 start-page: 534 year: 2011 ident: key20200713174738_b36-ijmm-41-04-1909 article-title: The role of microRNA in modulating myocardial ischemia-reperfusion injury publication-title: Physiol Genomics doi: 10.1152/physiolgenomics.00130.2010 contributor: fullname: Ye – volume: 6 start-page: 2068 year: 2016 ident: key20200713174738_b3-ijmm-41-04-1909 article-title: Crucial role of mir-433 in regulating cardiac fibrosis publication-title: Theranostics doi: 10.7150/thno.15007 contributor: fullname: Tao – volume: 15 start-page: 1282 year: 2013 ident: key20200713174738_b24-ijmm-41-04-1909 article-title: Nfat and mir-25 cooperate to reactivate the transcription factor hand2 in heart failure publication-title: Nat Cell Biol doi: 10.1038/ncb2866 contributor: fullname: Dirkx – volume: 103 start-page: 670 year: 2001 ident: key20200713174738_b42-ijmm-41-04-1909 article-title: Differential activation of signal transduction pathways in human hearts with hypertrophy versus advanced heart failure publication-title: Circulation doi: 10.1161/01.CIR.103.5.670 contributor: fullname: Haq – volume: 469 start-page: 336 year: 2011 ident: key20200713174738_b13-ijmm-41-04-1909 article-title: Pervasive roles of microRNAs in cardiovascular biology publication-title: Nature doi: 10.1038/nature09783 contributor: fullname: Small – volume: 39 start-page: 672 year: 2002 ident: key20200713174738_b43-ijmm-41-04-1909 article-title: Pressure overload hypertrophy and congestive heart failure. Where is the 'Achilles' heel' publication-title: J Am Coll Cardiol doi: 10.1016/S0735-1097(01)01790-9 contributor: fullname: Peterson – volume: 456 start-page: 980 year: 2008 ident: key20200713174738_b34-ijmm-41-04-1909 article-title: MicroRNA-21 contributes to myocardial disease by stimulating map kinase signalling in fibroblasts publication-title: Nature doi: 10.1038/nature07511 contributor: fullname: Thum – volume: 109 start-page: 404 year: 2017 ident: key20200713174738_b18-ijmm-41-04-1909 article-title: Large accumulation of collagen and increased activation of mast cells in hearts of mice with hyperlipidemia publication-title: Arq Bras Cardiol contributor: fullname: Cheng – volume: 17 start-page: pii: E749 year: 2016 ident: key20200713174738_b27-ijmm-41-04-1909 article-title: Overview of MicroRNAs in cardiac hypertrophy, fibrosis, and apoptosis publication-title: Int J Mol Sci doi: 10.3390/ijms17050749 contributor: fullname: Wang – volume: 7 start-page: 203 year: 2014 ident: key20200713174738_b25-ijmm-41-04-1909 article-title: Micrornas in heart failure: Is the picture becoming less mirky publication-title: Circ Heart Fail doi: 10.1161/CIRCHEARTFAILURE.113.000266 contributor: fullname: Melman – volume: 40 start-page: 1511 year: 2017 ident: key20200713174738_b7-ijmm-41-04-1909 article-title: MicroRNA-135a is involved in podocyte injury in a transient receptor potential channel 1-dependent manner publication-title: Int J Mol Med doi: 10.3892/ijmm.2017.3152 contributor: fullname: Yang – volume: 35 start-page: 893 year: 2015 ident: key20200713174738_b28-ijmm-41-04-1909 article-title: Effects of miRNA-455 on cardiac hypertrophy induced by pressure overload publication-title: Int J Mol Med doi: 10.3892/ijmm.2015.2105 contributor: fullname: Wu – volume: 24 start-page: 45 year: 2013 ident: key20200713174738_b46-ijmm-41-04-1909 article-title: In vivo RNAi screening identifies a leukemia-specific dependence on integrin beta 3 signaling publication-title: Cancer Cell doi: 10.1016/j.ccr.2013.05.004 contributor: fullname: Miller – volume: 16 start-page: 313 year: 2011 ident: key20200713174738_b19-ijmm-41-04-1909 article-title: Rapid and quantitative assessment of cell quality, identity, and functionality for cell-based assays using real-time cellular analysis publication-title: J Biomol Screen doi: 10.1177/1087057110397359 contributor: fullname: Irelan – volume: 40 start-page: 2015 year: 2015 ident: key20200713174738_b47-ijmm-41-04-1909 article-title: Integrin β3 haploinsufficiency modulates serotonin transport and antidepressant-sensitive behavior in mice publication-title: Neuropsychopharmacology doi: 10.1038/npp.2015.51 contributor: fullname: Mazalouskas – volume: 19 start-page: 177 year: 2017 ident: key20200713174738_b39-ijmm-41-04-1909 article-title: Myocardial fibrosis: Biomedical research from bench to bedside publication-title: Eur J Heart Fail doi: 10.1002/ejhf.696 contributor: fullname: Gyöngyösi – volume: 10 start-page: 15 year: 2013 ident: key20200713174738_b40-ijmm-41-04-1909 article-title: Myofibroblast-mediated mechanisms of pathological remodelling of the heart publication-title: Nat Rev Cardiol doi: 10.1038/nrcardio.2012.158 contributor: fullname: Weber – volume: 10 start-page: M110 005397 year: 2011 ident: key20200713174738_b45-ijmm-41-04-1909 article-title: Proteomics identification of ITGB3 as a key regulator in reactive oxygen species-induced migration and invasion of colorectal cancer cells publication-title: Mol Cell Proteomics doi: 10.1074/mcp.M110.005397 contributor: fullname: Lei – volume: 61 start-page: 91 year: 1997 ident: key20200713174738_b2-ijmm-41-04-1909 article-title: Toward molecular strategies for heart disease-past, present, future publication-title: Jpn Circ J doi: 10.1253/jcj.61.91 contributor: fullname: Chien – volume: 113 start-page: 676 year: 2013 ident: key20200713174738_b11-ijmm-41-04-1909 article-title: Non-coding RNAs in cardiac remodeling and heart failure publication-title: Circ Res doi: 10.1161/CIRCRESAHA.113.300226 contributor: fullname: Kumarswamy – volume: 11 start-page: 655 year: 2014 ident: key20200713174738_b9-ijmm-41-04-1909 article-title: Noncoding RNAs and myocardial fibrosis publication-title: Nat Rev Cardiol doi: 10.1038/nrcardio.2014.125 contributor: fullname: Thum – volume: 11 start-page: 55 year: 2012 ident: key20200713174738_b32-ijmm-41-04-1909 article-title: Plasma levels of lipometabolism-related miR-122 and mir-370 are increased in patients with hyperlipidemia and associated with coronary artery disease publication-title: Lipids Health Dis doi: 10.1186/1476-511X-11-55 contributor: fullname: Gao – volume: 19 start-page: 608 year: 2015 ident: key20200713174738_b1-ijmm-41-04-1909 article-title: Attenuation of microrna-16 derepresses the cyclins d1, d2 and e1 to provoke cardiomyocyte hypertrophy publication-title: J Cell Mol Med doi: 10.1111/jcmm.12445 contributor: fullname: Huang – volume: 63 start-page: 920 year: 2014 ident: key20200713174738_b26-ijmm-41-04-1909 article-title: Circulating miR-29a, among other up-regulated microRNAs, is the only biomarker for both hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2013.09.041 contributor: fullname: Roncarati – volume: 40 start-page: 523 year: 2017 ident: key20200713174738_b8-ijmm-41-04-1909 article-title: miR-27 inhibits the NF-κB signaling pathway by targetingleptin in osteoarthritic chondrocytes publication-title: Int J Mol Med doi: 10.3892/ijmm.2017.3021 contributor: fullname: Zhou – volume: 284 start-page: 29514 year: 2009 ident: key20200713174738_b37-ijmm-41-04-1909 article-title: MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction publication-title: J Biol Chem doi: 10.1074/jbc.M109.027896 contributor: fullname: Dong – volume: 283 start-page: 22295 year: 2008 ident: key20200713174738_b15-ijmm-41-04-1909 article-title: Nfatc2 is a necessary mediator of calcineurin-dependent cardiac hypertrophy and heart failure publication-title: J Biol Chem doi: 10.1074/jbc.M801296200 contributor: fullname: Bourajjaj – volume: 19 start-page: 707 year: 2015 ident: key20200713174738_b10-ijmm-41-04-1909 article-title: Non-coding RNAs as direct and indirect modulators of epigenetic mechanism regulation of cardiac fibrosis publication-title: Expert Opin Ther Targets doi: 10.1517/14728222.2014.1001740 contributor: fullname: Tao – volume: 10 start-page: e0123477 year: 2015 ident: key20200713174738_b31-ijmm-41-04-1909 article-title: Plasma levels of microRNA-145 are associated with severity of coronary artery disease publication-title: PLoS One doi: 10.1371/journal.pone.0123477 contributor: fullname: Gao – volume: 25 start-page: 402 year: 2001 ident: key20200713174738_b21-ijmm-41-04-1909 article-title: Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔC T method publication-title: Methods doi: 10.1006/meth.2001.1262 contributor: fullname: Livak – volume: 12 start-page: 847 year: 2013 ident: key20200713174738_b29-ijmm-41-04-1909 article-title: Micrornas and other non-coding RNAs as targets for anticancer drug development publication-title: Nat Rev Drug Discov doi: 10.1038/nrd4140 contributor: fullname: Ling – volume: 11 start-page: 222 year: 2013 ident: key20200713174738_b33-ijmm-41-04-1909 article-title: Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis publication-title: J Transl Med doi: 10.1186/1479-5876-11-222 contributor: fullname: Wang – volume: 16 start-page: 2150 year: 2012 ident: key20200713174738_b35-ijmm-41-04-1909 article-title: MicroRNA-24 regulates cardiac fibrosis after myocardial infarction publication-title: J Cell Mol Med doi: 10.1111/j.1582-4934.2012.01523.x contributor: fullname: Wang – volume: 100 start-page: 279 year: 2012 ident: key20200713174738_b12-ijmm-41-04-1909 article-title: MicroRNAs in heart development publication-title: Curr Top Dev Biol doi: 10.1016/B978-0-12-387786-4.00009-9 contributor: fullname: Espinoza-Lewis – volume: 123 start-page: 40 year: 2017 ident: key20200713174738_b16-ijmm-41-04-1909 article-title: Glycine prevents pressure overload induced cardiac hypertrophy mediated by glycine receptor publication-title: Biochem Pharmacol doi: 10.1016/j.bcp.2016.11.008 contributor: fullname: Lu – volume: 74 start-page: 280 year: 2016 ident: key20200713174738_b30-ijmm-41-04-1909 article-title: Decision-making microRNAs (miR-124, -133a/b, -34a and -134) in patients with occluded target vessel in acute coronary syndrome publication-title: Kardiol Pol doi: 10.5603/KP.a2015.0174 contributor: fullname: Gacoń – volume: 126 start-page: 800 year: 2012 ident: key20200713174738_b5-ijmm-41-04-1909 article-title: Cardiac fibrosis revisited by microRNA therapeutics publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.112.125013 contributor: fullname: Thum |
SSID | ssj0025498 |
Score | 2.3696115 |
Snippet | MicroRNA (miRNA/miR) dysregulation has been reported to be fundamental in the development and progression of cardiac hypertrophy and fibrosis. In the present... |
SourceID | pubmedcentral proquest gale crossref pubmed |
SourceType | Open Access Repository Aggregation Database Index Database |
StartPage | 1909 |
SubjectTerms | Cardiomyocytes Cardiomyopathy Cardiovascular disease Care and treatment Coronary vessels Development and progression Fibroblasts Fibrosis Gene expression Genetic aspects Health aspects Heart diseases Heart failure Immunoglobulins Kinases Laboratory animals MicroRNA Ostomy Pathology Rodents Studies Surgery |
Title | MicroRNA-327 regulates cardiac hypertrophy and fibrosis induced by pressure overload |
URI | https://www.ncbi.nlm.nih.gov/pubmed/29393356 https://www.proquest.com/docview/2012842253 https://pubmed.ncbi.nlm.nih.gov/PMC5810199 |
Volume | 41 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELboVkJcEG8WSuUDEqdAEsd2fEILalUh7aqqWmlvlp_qIkhKsj3w75lJvMuGA8fElpzMjD3zjedByHseWHTexMyU6LqJLEdHE8sEpvxYZmtj0KG_XImLm-rbmq-Tw61PYZW7M3E4qH3r0EcOIB1PUpA-9vnuV4Zdo_B2NbXQOCLHJSCFfEaOv5ytLq_2kAvQz5AMV6A3TnIxlm0EJV1-2nz_iZnoRf2RVdiL_UAt_Xs4H2inaeTkgSo6f0IeJxuSLkamPyUPQvOMPFymW_Ln5HqJUXZXq0XGSkm7sdt86KkbpMHRW8Ce3bZrgcLUNJ5GgMxtv-kp4HPgtKf2Nx3iY--7QDHE80dr_Atyc352_fUiS90TMlfVfJsxURuXW1coXzOrYgFqSQV4AQgl-soX1nEnvXJC5s54CZqbSRZ5ZDEGkSv2ksyatgmvCYVNL3Me66B8VeW2tIKDVeOsz41wSoU5-bAjnr4bi2RoABdIZo1k1khmjWSGmUhbjbsHCOhMSgKAdbAOlV5wBjaEqOp8Tk4mM0Hq3XR4xx2ddl2v_8rInLwaGbX_HjBrFGNczImcsHA_AetsT0eaze1Qb5tjETSl3vx_ybfkEf7mGNVzQmbb7j68A4Nla0_JkVzL0ySb8LS6XP4BBGXtAQ |
link.rule.ids | 230,315,783,787,888,12068,21400,27936,27937,31731,33756,43322,43817,74079,74636 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELZKKwEXxKtloYAPSJxCk3XsxCe0oFZb6K5QtZV6s_zUblWSkmwP_HtmEu-y4cA1seRkZjwz33gehHzgngXrdEj0GEM3gaUYaGKJwJIfw0ypNQb0Z3Mxvcq_XfPrGHBrY1rlRid2itrVFmPkANJRk4L0sc93vxKcGoW3q3GExgNygK2qAHwdfDmd_7jcQi5AP10xXIbRuIKLvm0jGOnxyermJ1aiZ-UnluMs9h2z9K9y3rFOw8zJHVN09pQ8iT4knfRMf0b2fPWcPJzFW_IXZDHDLLvL-SRh44I2_bR531LbSYOlS8CezbqpgcJUV44GgMx1u2op4HPgtKPmN-3yY-8bTzHF87bW7iW5OjtdfJ0mcXpCYvOSrxMmSm1TYzPpSmZkyMAsSQ8PAKEEl7vMWG4LJ60oUqtdAZabFSzwwELwIpXskOxXdeVfEQqHvkh5KL10eZ6asREcvBprXKqFldKPyMcN8dRd3yRDAbhAMisks0IyKyQzrETaKjw9QECrYxEA7IN9qNSEM_AhRF6mI3I8WAlSb4evN9xR8dS16q-MjMhRz6jt94BbIxnjYkSKAQu3C7DP9vBNtVp2_bY5NkGT8vX_t3xPHk0Xswt1cT7__oY8xl_uM3yOyf66ufdvwXlZm3dRQv8ARo3uCA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagSBUXRHkuFPABiVNoso7t-FStSlflsSuEWmlvlp_qVpCUZHvg3zOTeNsNB66JJScz45n5xvMg5D0PLDpvYmamGLqJLMdAE8sElvxYZitjMKC_WIqzi_LLiq9S_lOX0iq3OrFX1L5xGCMHkI6aFKSPHcWUFvH90_z4-neGE6TwpjWN07hPHkhAKSjhcnUHvgAH9WVxBcblJBdDA0cw19Oj9dUvrEkvqo-sxKnsOwbqXzW9Y6fGOZQ7Rmn-mDxK3iSdDew_IPdC_YTsL9J9-VNyvsB8ux_LWcamkrbD3PnQUdfLhaOXgELbTdsArampPY0Anptu3VFA6sBzT-0f2mfK3rSBYrLnz8b4Z-Rifnp-cpalOQqZKyu-yZiojMutK5SvmFWxAAOlAjwArBJ96QvruJNeOSFzZ7wEG84kizyyGIPIFXtO9uqmDi8JheMvcx6roHxZ5nZqBQf_xlmfG-GUChPyYUs8fT20y9AAM5DMGsmskcwayQwrkbYazxEQ0JlUDgD7YEcqPeMMvAlRVvmEHI5Wgvy78estd3Q6f52-k5YJeTEw6vZ7wMFRjHExIXLEwtsF2HF7_KZeX_adtzm2Q1Pq1f-3fEf2QTT1t8_Lr6_JQ_zjIdXnkOxt2pvwBryYjX3bi-dfUoDw1w |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=MicroRNA-327+regulates+cardiac+hypertrophy+and+fibrosis+induced+by+pressure+overload&rft.jtitle=International+journal+of+molecular+medicine&rft.au=Ji%2C+Yue&rft.au=Qiu%2C+Ming&rft.au=Shen%2C+Yejiao&rft.au=Gao%2C+Li&rft.date=2018-04-01&rft.issn=1107-3756&rft.eissn=1791-244X&rft_id=info:doi/10.3892%2Fijmm.2018.3428&rft.externalDBID=n%2Fa&rft.externalDocID=10_3892_ijmm_2018_3428 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1107-3756&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1107-3756&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1107-3756&client=summon |